| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |